HIPPOLYTA LIMITED

2021-03-012022-02-282022-02-28false10637198HIPPOLYTA LIMITED2022-11-24iso4217:GBPxbrli:pure106371982021-03-01106371982022-02-28106371982021-03-012022-02-28106371982020-03-01106371982021-02-28106371982020-03-012021-02-2810637198bus:SmallEntities2021-03-012022-02-2810637198bus:AuditExempt-NoAccountantsReport2021-03-012022-02-2810637198bus:FullAccounts2021-03-012022-02-2810637198bus:PrivateLimitedCompanyLtd2021-03-012022-02-2810637198core:WithinOneYear2022-02-2810637198core:AfterOneYear2022-02-2810637198core:WithinOneYear2021-02-2810637198core:AfterOneYear2021-02-2810637198core:ShareCapital2022-02-2810637198core:SharePremium2022-02-2810637198core:RevaluationReserve2022-02-2810637198core:OtherReservesSubtotal2022-02-2810637198core:RetainedEarningsAccumulatedLosses2022-02-2810637198core:ShareCapital2021-02-2810637198core:SharePremium2021-02-2810637198core:RevaluationReserve2021-02-2810637198core:OtherReservesSubtotal2021-02-2810637198core:RetainedEarningsAccumulatedLosses2021-02-2810637198core:LandBuildings2022-02-2810637198core:PlantMachinery2022-02-2810637198core:Vehicles2022-02-2810637198core:FurnitureFittings2022-02-2810637198core:OfficeEquipment2022-02-2810637198core:NetGoodwill2022-02-2810637198core:IntangibleAssetsOtherThanGoodwill2022-02-2810637198core:ListedExchangeTraded2022-02-2810637198core:UnlistedNon-exchangeTraded2022-02-2810637198core:LandBuildings2021-02-2810637198core:PlantMachinery2021-02-2810637198core:Vehicles2021-02-2810637198core:FurnitureFittings2021-02-2810637198core:OfficeEquipment2021-02-2810637198core:NetGoodwill2021-02-2810637198core:IntangibleAssetsOtherThanGoodwill2021-02-2810637198core:ListedExchangeTraded2021-02-2810637198core:UnlistedNon-exchangeTraded2021-02-2810637198core:LandBuildings2021-03-012022-02-2810637198core:PlantMachinery2021-03-012022-02-2810637198core:Vehicles2021-03-012022-02-2810637198core:FurnitureFittings2021-03-012022-02-2810637198core:OfficeEquipment2021-03-012022-02-2810637198core:NetGoodwill2021-03-012022-02-2810637198core:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2810637198core:ListedExchangeTraded2021-03-012022-02-2810637198core:UnlistedNon-exchangeTraded2021-03-012022-02-2810637198core:MoreThanFiveYears2021-03-012022-02-2810637198core:Non-currentFinancialInstruments2022-02-2810637198core:Non-currentFinancialInstruments2021-02-2810637198dpl:CostSales2021-03-012022-02-2810637198dpl:DistributionCosts2021-03-012022-02-2810637198dpl:AdministrativeExpenses2021-03-012022-02-2810637198core:LandBuildings2021-03-012022-02-2810637198core:PlantMachinery2021-03-012022-02-2810637198core:Vehicles2021-03-012022-02-2810637198core:FurnitureFittings2021-03-012022-02-2810637198core:OfficeEquipment2021-03-012022-02-2810637198core:NetGoodwill2021-03-012022-02-2810637198core:IntangibleAssetsOtherThanGoodwill2021-03-012022-02-2810637198dpl:GroupUndertakings2021-03-012022-02-2810637198dpl:ParticipatingInterests2021-03-012022-02-2810637198dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-012022-02-2810637198core:ListedExchangeTraded2021-03-012022-02-2810637198dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-012022-02-2810637198core:UnlistedNon-exchangeTraded2021-03-012022-02-2810637198dpl:CostSales2020-03-012021-02-2810637198dpl:DistributionCosts2020-03-012021-02-2810637198dpl:AdministrativeExpenses2020-03-012021-02-2810637198core:LandBuildings2020-03-012021-02-2810637198core:PlantMachinery2020-03-012021-02-2810637198core:Vehicles2020-03-012021-02-2810637198core:FurnitureFittings2020-03-012021-02-2810637198core:OfficeEquipment2020-03-012021-02-2810637198core:NetGoodwill2020-03-012021-02-2810637198core:IntangibleAssetsOtherThanGoodwill2020-03-012021-02-2810637198dpl:GroupUndertakings2020-03-012021-02-2810637198dpl:ParticipatingInterests2020-03-012021-02-2810637198dpl:GroupUndertakingscore:ListedExchangeTraded2020-03-012021-02-2810637198core:ListedExchangeTraded2020-03-012021-02-2810637198dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2020-03-012021-02-2810637198core:UnlistedNon-exchangeTraded2020-03-012021-02-2810637198core:NetGoodwill2022-02-2810637198core:IntangibleAssetsOtherThanGoodwill2022-02-2810637198core:LandBuildings2022-02-2810637198core:PlantMachinery2022-02-2810637198core:Vehicles2022-02-2810637198core:FurnitureFittings2022-02-2810637198core:OfficeEquipment2022-02-2810637198core:AfterOneYear2022-02-2810637198core:WithinOneYear2022-02-2810637198core:ListedExchangeTraded2022-02-2810637198core:UnlistedNon-exchangeTraded2022-02-2810637198core:ShareCapital2022-02-2810637198core:SharePremium2022-02-2810637198core:RevaluationReserve2022-02-2810637198core:OtherReservesSubtotal2022-02-2810637198core:RetainedEarningsAccumulatedLosses2022-02-2810637198core:NetGoodwill2021-02-2810637198core:IntangibleAssetsOtherThanGoodwill2021-02-2810637198core:LandBuildings2021-02-2810637198core:PlantMachinery2021-02-2810637198core:Vehicles2021-02-2810637198core:FurnitureFittings2021-02-2810637198core:OfficeEquipment2021-02-2810637198core:AfterOneYear2021-02-2810637198core:WithinOneYear2021-02-2810637198core:ListedExchangeTraded2021-02-2810637198core:UnlistedNon-exchangeTraded2021-02-2810637198core:ShareCapital2021-02-2810637198core:SharePremium2021-02-2810637198core:RevaluationReserve2021-02-2810637198core:OtherReservesSubtotal2021-02-2810637198core:RetainedEarningsAccumulatedLosses2021-02-2810637198core:NetGoodwill2020-03-0110637198core:IntangibleAssetsOtherThanGoodwill2020-03-0110637198core:LandBuildings2020-03-0110637198core:PlantMachinery2020-03-0110637198core:Vehicles2020-03-0110637198core:FurnitureFittings2020-03-0110637198core:OfficeEquipment2020-03-0110637198core:AfterOneYear2020-03-0110637198core:WithinOneYear2020-03-0110637198core:ListedExchangeTraded2020-03-0110637198core:UnlistedNon-exchangeTraded2020-03-0110637198core:ShareCapital2020-03-0110637198core:SharePremium2020-03-0110637198core:RevaluationReserve2020-03-0110637198core:OtherReservesSubtotal2020-03-0110637198core:RetainedEarningsAccumulatedLosses2020-03-0110637198core:AfterOneYear2021-03-012022-02-2810637198core:WithinOneYear2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:CostValuation2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-03-012022-02-2810637198core:Non-currentFinancialInstrumentscore:CostValuation2022-02-2810637198core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-2810637198core:Non-currentFinancialInstrumentscore:CostValuation2021-02-2810637198core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-02-2810637198core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-02-2810637198bus:Director12021-03-012022-02-28

HIPPOLYTA LIMITED

Registered Number
10637198
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2022

HIPPOLYTA LIMITED

Company Information
for the year from 1 March 2021 to 28 February 2022


Directors	BROWN, Catherine Margaret


Registered Address	5 Deansway
	Worcester
	WR1 2JG


Registered Number	10637198 (England and Wales)

HIPPOLYTA LIMITED

Balance Sheet as at
28 February 2022

	Notes	2022		2021
		£	£	£	£
Current assets
Debtors	6	1,087		199
		1,087		199
Creditors amounts falling due within one year	7	(42,990)		(22,126)
Net current assets (liabilities)			(41,903)		(21,927)
Total assets less current liabilities			(41,903)		(21,927)
Net assets			(41,903)		(21,927)
Capital and reserves
Called up share capital			100		100
Profit and loss account			(42,003)		(22,027)
Shareholders' funds			(41,903)		(21,927)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.

The financial statements were approved and authorised for issue by the Director on 24 November 2022, and are signed on its behalf by:

BROWN, Catherine Margaret
Director
Registered Company No. 10637198

HIPPOLYTA LIMITED

Notes to the Financial Statements
for the year ended 28 February 2022

1.	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Compliance with applicable reporting framework
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

3.	Principal activities
	The company's principal activity during the period was management consultancy.

4.	Accounting policies

	Revenue recognition policy
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue recognition policy

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Foreign currency translation and operations policy
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation and operations policy

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

5.	Employee information


		2022		2021
	Average number of employees during the year	1		1

6.	Debtors

	2022	2021
	£	£
Trade debtors / trade receivables	806	-
Other debtors	281	199
Total	1,087	199


	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

7.	Creditors within one year

	2022	2021
	£	£
Other creditors	42,990	22,126
Total	42,990	22,126


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.